West Europe
United Kingdom· FromeModerna and Merck's mRNA cancer vaccine shows promising trial results
Moderna and Merck announced that their personalized mRNA cancer vaccine significantly reduced the risk of melanoma recurrence and spread in a late-stage trial.
Quorum · collective opinions
Moderna and Merck's mRNA cancer vaccine shows promising results
First report 7h agoLast update 5h ago1 takes▲ 1
optimism for new treatmentpositiveShow 3 posts
started 7h ago•Last update 5h ago
There is significant hope and excitement surrounding the positive trial results of the mRNA cancer vaccine, indicating a major breakthrough in cancer treatment.
iWitness comments
No comments yet — be the first to weigh in.